Mediar Therapeutics
Preclinical stage biotech company developing medicines to halt, or even reverse, fibrosis. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€309—464m (Dealroom.co estimates Mar 2023.)
Cambridge Massachusetts (HQ)
Authorizing premium user...